Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study.
Saved in:
| Title: | Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study. |
|---|---|
| Authors: | Gustine JN; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA., Staron A; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA., Szalat RE; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA., Mendelson LM; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA., Joshi T; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA., Ruberg FL; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.; Section of Cardiovascular Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA., Siddiqi O; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.; Section of Cardiovascular Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA., Gopal DM; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.; Section of Cardiovascular Medicine, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA., Edwards CV; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA., Havasi A; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.; Section of Nephrology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA., Kaku M; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.; Section of Neurology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA., Lau KHV; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.; Section of Neurology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA., Berk JL; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.; Section of Pulmonology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA., Sloan JM; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA., Sanchorawala V; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.; Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts, USA. |
| Source: | American journal of hematology [Am J Hematol] 2022 Sep; Vol. 97 (9), pp. 1189-1199. Date of Electronic Publication: 2022 Jul 05. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1096-8652 |
|---|---|
| DOI: | 10.1002/ajh.26641 |
